UBS Group’s ChampionX CHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-602,783
| Closed | -$15M | – | 10379 |
|
|
2025
Q2 | $15M | Sell |
602,783
-1,169,876
| -66% | -$29.5M | ﹤0.01% | 2682 |
|
|
2025
Q1 | $52.8M | Buy |
1,772,659
+817,970
| +86% | +$23.9M | 0.01% | 1430 |
|
|
2024
Q4 | $26M | Buy |
954,689
+657,975
| +222% | +$19.6M | ﹤0.01% | 2054 |
|
|
2024
Q3 | $8.95M | Buy |
296,714
+178,977
| +152% | +$5.65M | ﹤0.01% | 2477 |
|
|
2024
Q2 | $3.91M | Sell |
117,737
-45,464
| -28% | -$1.55M | ﹤0.01% | 3103 |
|
|
2024
Q1 | $5.86M | Sell |
163,201
-519
| -0.3% | -$15.5K | ﹤0.01% | 2799 |
|
|
2023
Q4 | $4.78M | Buy |
163,720
+133,867
| +448% | +$4.14M | ﹤0.01% | 2835 |
|
|
2023
Q3 | $1.06M | Buy |
29,853
+14,589
| +96% | +$518K | ﹤0.01% | 4014 |
|
|
2023
Q2 | $474K | Sell |
15,264
-73,720
| -83% | -$2.03M | ﹤0.01% | 4867 |
|
|
2023
Q1 | $2.41M | Buy |
88,984
+11,446
| +15% | +$342K | ﹤0.01% | 3227 |
|
|
2022
Q4 | $2.25M | Buy |
77,538
+53,496
| +223% | +$1.48M | ﹤0.01% | 3278 |
|
|
2022
Q3 | $470K | Buy |
24,042
+6,349
| +36% | +$131K | ﹤0.01% | 4390 |
|
|
2022
Q2 | $351K | Sell |
17,693
-42,328
| -71% | -$956K | ﹤0.01% | 4538 |
|
|
2022
Q1 | $1.47M | Sell |
60,021
-136,505
| -69% | -$3.16M | ﹤0.01% | 3735 |
|
|
2021
Q4 | $3.97M | Buy |
196,526
+119,890
| +156% | +$2.82M | ﹤0.01% | 3077 |
|
|
2021
Q3 | $1.71M | Sell |
76,636
-22,911
| -23% | -$524K | ﹤0.01% | 3708 |
|
|
2021
Q2 | $2.55M | Sell |
99,547
-33,340
| -25% | -$811K | ﹤0.01% | 3349 |
|
|
2021
Q1 | $2.89M | Sell |
132,887
-20,443
| -13% | -$397K | ﹤0.01% | 3183 |
|
|
2020
Q4 | $2.35M | Sell |
153,330
-15,959
| -9% | -$177K | ﹤0.01% | 3258 |
|
|
2020
Q3 | $1.35M | Buy |
169,289
+51,395
| +44% | +$495K | ﹤0.01% | 3415 |
|
|
2020
Q2 | $1.15M | Buy |
117,894
+107,100
| +992% | +$981K | ﹤0.01% | 3388 |
|
|
2020
Q1 | $62K | Sell |
10,794
-63,516
| -85% | -$1.32M | ﹤0.01% | 5653 |
|
|
2019
Q4 | $2.51M | Buy |
74,310
+50,851
| +217% | +$1.38M | ﹤0.01% | 3321 |
|
|
2019
Q3 | $634K | Buy |
23,459
+236
| +1% | +$6.89K | ﹤0.01% | 4354 |
|
|
2019
Q2 | $779K | Sell |
23,223
-6,263
| -21% | -$227K | ﹤0.01% | 3950 |
|
|
2019
Q1 | $1.21M | Buy |
29,486
+11,846
| +67% | +$438K | ﹤0.01% | 3417 |
|
|
2018
Q4 | $478K | Sell |
17,640
-8,514
| -33% | -$313K | ﹤0.01% | 4310 |
|
|
2018
Q3 | $1.14M | Sell |
26,154
-15,637
| -37% | -$655K | ﹤0.01% | 3724 |
|
|
2018
Q2 | $1.75M | Buy |
+41,791
| New | +$1.71M | ﹤0.01% | 3290 |
|
Other funds holding CHX
UBS Group's CHX Position: Q3 2025 in Review
UBS Group sold out of ChampionX (CHX) in Q3 2025, closing a stake of 602,783 shares — an estimated $15M sold.
UBS Group first reported a position in CHX in Q2 2018 and held it in 29 quarters. The position peaked at $52.8M in Q1 2025. 3 funds tracked by Wall St. Rank hold CHX as of Q3 2025.
- UBS Group reported no remaining ChampionX position as of Q3 2025 after selling out during the quarter.
- UBS Group sold 602,783 ChampionX shares in Q3 2025, an estimated $15M.
- UBS Group first reported a position in ChampionX in Q2 2018 and held it in 29 quarters.
- UBS Group's ChampionX position peaked at $52.8M in Q1 2025.
- 3 funds tracked by Wall St. Rank held ChampionX as of Q3 2025.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.